GenSight Biologics
SIGHT.PA
#9822
Rank
A$47.34 M
Marketcap
$0.37
Share price
-9.93%
Change (1 day)
-45.93%
Change (1 year)

Earnings for GenSight Biologics (SIGHT.PA)

Earnings in 2023: -A$47.95 Million

According to GenSight Biologics's latest financial reports the company's current earnings are A$1.4 Million. In 2023 the company made an earning of -A$47.95 Million, an increase over its 2022 earnings that were of -A$49.01 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for GenSight Biologics from 2013 to 2023

Annual earnings

Year Earnings Change
2023-A$47.95 Million-2.16%
2022-A$49.01 Million-8.58%
2021-A$53.61 Million-22.54%
2020-A$69.21 Million21.01%
2019-A$57.19 Million-9.66%
2018-A$63.3 Million32.28%
2017-A$47.86 Million24.57%
2016-A$38.42 Million55.57%
2015-A$24.7 Million84%
2014-A$13.42 Million112.64%
2013-A$6.32 Million